Caxton Associates (New York)’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-44,308
Closed -$1.3M 490
2023
Q2
$1.3M Buy
44,308
+31,230
+239% +$861K 0.19% 118
2023
Q1
$367K Sell
13,078
-3,882
-23% -$109K 0.06% 317
2022
Q4
$462K Sell
16,960
-67,235
-80% -$1.79M 0.03% 254
2022
Q3
$2.01M Buy
84,195
+39,811
+90% +$1.09M 0.27% 33
2022
Q2
$1.24M Sell
44,384
-26,147
-37% -$761K 0.12% 80
2022
Q1
$2.06M Buy
70,531
+20,190
+40% +$628K 0.17% 40
2021
Q4
$1.75M Buy
+50,341
New +$1.79M 0.18% 53
2021
Q3
Sell
-29,460
Closed -$975K 500
2021
Q2
$975K Buy
29,460
+9,600
+48% +$333K 0.11% 75
2021
Q1
$708K Buy
+19,860
New +$706K 0.06% 109
2020
Q4
Sell
-24,074
Closed -$620K 216
2020
Q3
$620K Buy
+24,074
New +$640K 0.07% 91
2020
Q2
Sell
-36,319
Closed -$805K 526
2020
Q1
$805K Buy
+36,319
New +$1.01M 0.15% 82

Other funds holding GNTX

Caxton Associates (New York)'s GNTX Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Gentex (GNTX) in Q3 2023, closing a stake of 44,308 shares — an estimated $1.3M sold.

Caxton Associates (New York) first reported a position in GNTX in Q1 2020 and held it in 11 quarters. The position peaked at $2.06M in Q1 2022. 498 funds tracked by Wall St. Rank hold GNTX as of Q3 2023.

  • Caxton Associates (New York) reported no remaining Gentex position as of Q3 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 44,308 Gentex shares in Q3 2023, an estimated $1.3M.
  • Caxton Associates (New York) first reported a position in Gentex in Q1 2020 and held it in 11 quarters.
  • Caxton Associates (New York)'s Gentex position peaked at $2.06M in Q1 2022.
  • 498 funds tracked by Wall St. Rank held Gentex as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.